Navigation Links
Same Genes Key to Early & Late-Onset Alzheimer's: Study
Date:2/2/2012

THURSDAY, Feb. 2 (HealthDay News) -- People who develop Alzheimer's disease late in life may have the same gene mutations linked to the inherited, early onset form of the condition, according to a new study.

Researchers from Washington University School of Medicine in St. Louis suggested this could lead to changes in the way Alzheimer's disease is classified.

"It's always been somewhat arbitrary, figuring out where early onset ends and late-onset begins. So I no longer look at early- and late-onset disease as being different illnesses. I think of them as stages along a continuum," said the study's senior investigator, Alison Goate, in a university news release. "I think it's reasonable to assume that at least some cases among both early- and late-onset disease have the same causes."

People who develop Alzheimer's at a younger age probably have more risk factors and fewer protective factors for the brain disorder than those who develop it later in life, Goate noted. In both age groups, however, the disease mechanism may be identical, she explained.

In conducting their research, published online Feb. 1 in PLoS One, researchers studied the genetic information of 440 families that had at least four relatives diagnosed with Alzheimer's disease.

Specifically, they analyzed five genes associated with dementia. Mutations in three of the genes they examined are a known cause of early-onset Alzheimer's disease. The other two genes studied have been linked to another form of inherited dementia, called frontotemporal dementia.

The investigators found rare variants in Alzheimer's-related genes in 13 percent of the samples analyzed.

"Changes in these genes were more common in Alzheimer's cases with a family history of dementia, compared to normal individuals. This suggests that some of these gene variants are likely contributing to Alzheimer's disease risk," said Goate, who is also co-director of the Hope Center Program on Protein Aggregation and Neurodegeneration.

According to the study's first author, Carlos Cruchaga, an assistant professor of psychiatry, "of those rare gene variants, we think about 5 percent likely contribute to Alzheimer's disease. That may not seem like a lot, but so many people have the late-onset form of Alzheimer's that even a very small percentage of patients with changes in these genes could represent very large numbers of affected individuals," he explained in the news release. "

The study authors also pointed out that they discovered some of the gene mutations associated with frontotemporal dementia in Alzheimer's patients, suggesting these patients were actually misdiagnosed.

The researchers suggested doctors should screen for genetic mutations among their patients with late-onset Alzheimer's who have strong family histories of the disease.

More information

The U.S. National Library of Medicine has more about Alzheimer's disease.

-- Mary Elizabeth Dallas

SOURCE: Washington University School of Medicine in St. Louis, news release, Feb. 1, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Genes linked to cancer could be easier to detect with liquid lasers
2. Mutations in 2 Genes Linked to Rare Autism-Related Disorder
3. Genes and timing of menopause
4. Inflammatory mediator promotes colorectal cancer by stifling protective genes
5. Your Taste for Fat May Reside in Your Genes
6. Tracking genes remote controls
7. Most Parents Tell Kids About Test Results for Breast Cancer Genes
8. Most parents who get tested for breast cancer genes share results with their children
9. Positive feedback and tumorigenesis
10. New book on angiogenesis from Cold Spring Harbor Laboratory Press
11. Researchers discover patterns of genes associated with timing of breast cancer recurrences
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Same Genes Key to Early & Late-Onset Alzheimer's: Study
(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
Breaking Medicine Technology: